Q/C Technologies Ownership | Who Owns Q/C Technologies?
Q/C Technologies Ownership Summary
Q/C Technologies is owned by 9.05% institutional investors, 7.53% insiders, and 83.42% retail investors. Bnp paribas arbitrage, snc is the largest institutional shareholder, holding 0% of QCLS shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.28% of its assets in Q/C Technologies shares.
QCLS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Q/C Technologies | 9.05% | 7.53% | 83.42% |
| Sector | Technology Stocks | 78.07% | 14.90% | 7.03% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bnp paribas arbitrage, snc | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bnp paribas arbitrage, snc | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bnp paribas arbitrage, snc | - | - | -300.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bnp paribas arbitrage, snc | - | - | -300.00 |
Sold Out
| Holder | Change |
|---|---|
| Bnp paribas arbitrage, snc | -300.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 21 | 23.53% | 736,752 | 17.40% | 9 | 14.93% | 11 | - | 4 | 300.00% |
| Mar 31, 2026 | 17 | -5.56% | 627,555 | -16.63% | 7 | 8.13% | 11 | - | 1 | - |
| Dec 31, 2025 | 18 | 63.64% | 752,721 | 4375.15% | 9 | 20462.51% | 11 | - | 1 | - |
| Sep 30, 2025 | 11 | - | 16,820 | - | - | - | 11 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 104.74K | 1.28% | -10.29K |
| Fidelity Extended Market Index | 41.10K | 0.50% | -77.00 |
| DFA US Small Cap I | 13.19K | 0.16% | - |
| Fidelity Series Total Market Index | 12.99K | 0.16% | 6.95K |
| Northern Trust Extended Eq Market Idx | 10.15K | 0.13% | 5.62K |
| NT Ext Equity Mkt Index Fund - Lending | 10.15K | 0.13% | 5.62K |
| Fidelity Total Market Index | 10.45K | 0.13% | 5.21K |
| NT Ext Equity Mkt Index Fund - NL | 7.73K | 0.10% | 7.72K |
| Spartan Extended Market Index Pool F | 6.09K | 0.08% | 34.00 |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 5.61K | 0.07% | 5.60K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 30, 2026 | Voss Chelsea Sierra | - | Buy | $5.52K |
| Sep 04, 2025 | PharmaCyte Biotech, Inc. | - | Buy | - |
| Nov 14, 2025 | PharmaCyte Biotech, Inc. | - | Buy | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | 1 | - |
| 2025 Q3 | - | - |
| 2020 Q4 | - | - |
QCLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools